FDA Approves COVID-19 Antibody Treatment

FDA Approves COVID-19 Antibody Treatment

The antibody treatment is approved for administration in hospitals and other health care facilities.

The FDA issued an emergency use authorization for Eli Lilly and Co.’s antibody therapy for coronavirus on November 9, according to CNN.

The pharmaceutical company’s single antibody treatment is the first monoclonal antibody that has been authorized to treat COVID-19. The antibody, which is called bamlanivimab, will be used to initiate an immune response against the virus.

Bamlanivimab is an antibody that is directed against the spike protein of SARS-CoV-2. The FDA authorized the treatment after a New England Journal of Medicine study found that it lowered the risk of hospitalization when used on patients with mild to moderate coronavirus cases.

“The FDA’s emergency authorization of bamlanivimab provides health care professionals on the frontline of this pandemic with another potential tool in treating COVID-19 patients,” said Dr. Patricia Cavazzoni, acting director of the FDA’s Center for Drug Evaluation and Research. “We will continue to evaluate new data on the safety and efficacy of bamlanivimab as they become available.”

Eli Lilly and Co. will ship the antibody treatment to a national distributor so that it can be distributed according to state’s allocation plans. More information can be found at fda.gov.

About the Author

Nikki Johnson-Bolden is an Associate Content Editor for Occupational Health & Safety.

Download Center

  • Lone Worker Safety Guide

    As organizations digitalize and remote operations become more commonplace, the number of lone workers is on the rise. These employees are at increased risk for unaddressed workplace accidents or emergencies. This guide was created to help employers better understand common lone worker risks and solutions for lone worker risk mitigation and incident prevention.

  • Online Safety Training Buyer's Guide

    Use this handy buyer's guide to learn the basics of selecting online safety training and how to use it at your workplace.

  • COVID Return-to-Work Checklist, Fall 2021

    Use this checklist as an aid to help your organization return to work during the COVID-19 pandemic in a safe and healthy manner.

  • SDS Buyer's Guide

    Learn to make informed decisions while searching for SDS Management Software.

  • Risk Matrix Guide

    Risk matrices come in many different shapes and sizes. Understanding the components of a risk matrix will allow you and your organization to manage risk effectively.

  • Industry Safe

Featured Whitepapers

OH&S Digital Edition

  • OHS Magazine Digital Edition - October 2021

    October 2021

    Featuring:

    • TRAINING
      On Route To Safe Material Handling
    • SAFETY CULTURE
      Normalization of Deviations in Performance
    • IH:INDOOR AIR QUALITY
      Arresting Fugitive Dusts
    • PPE:FOOT PROTECTION
      Safety Shoes Make the Outfit for Well-Protected Workers
    View This Issue